menu
    • menu

    Company profile for SpliceBio

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SpliceBio is a biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies. Our platform is based on technology developed in the Muir Lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. Pioneering A New Gene Therapy Modality: Protein Splicing. Our proprietary platform is based on technology developed in the Muir Lab at Princeton Un...
    SpliceBio is a biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies. Our platform is based on technology developed in the Muir Lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. Pioneering A New Gene Therapy Modality: Protein Splicing. Our proprietary platform is based on technology developed in the Muir Lab at Princeton University after more than 20 years of pioneering intein and protein engineering research by our co-founders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SpliceBioSpain_new Flag
    Country
    Country
    Spain
    Address
    Address
    Parc Científic de Barcelona Baldiri Reixac, 10 08028 Barcelona
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://splice.bio/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/splicebio/?trk=ppro_cprof
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/splicebiohq?lang=ca

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    EQT Life Sciences Co-Leads $135M Series B Financing for SpliceBio
    EQT Life Sciences Co-Leads $135M Series B Financing for SpliceBio

    11 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eqt-life-sciences-co-leads-usd-135-million-series-b-financing-in-splicebio-302478828.html

    PR NEWSWIRE
    11 Jun 2025
    Share Share
    SpliceBio Doses First Patient in Phase 1/2 ASTRA Study of SB-007
    SpliceBio Doses First Patient in Phase 1/2 ASTRA Study of SB-007

    13 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/splicebio-announces-first-patient-dosed-in-phase-12-astra-study-of-sb-007-a-dual-aav-gene-therapy-for-stargardt-disease-302400963.html

    PR NEWSWIRE
    13 Mar 2025
    Share Share
    SpliceBio’s SB-007 Cleared By FDA For Stargardt Disease Phase 1/2 Trial
    SpliceBio’s SB-007 Cleared By FDA For Stargardt Disease Phase 1/2 Trial

    12 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/splicebio-announces-us-fda-ind-clearance-of-sb-007-to-commence-phase-12-clinical-study-in-patients-with-stargardt-disease-302329356.html

    PR NEWSWIRE
    12 Dec 2024
    Share Share
    SpliceBio sparks eye disease gene therapy collab with Roche unit
    SpliceBio sparks eye disease gene therapy collab with Roche unit

    17 Oct 2023

    // Annalee Armstrong FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/splicebio-sparks-eye-disease-gene-therapy-collab-roche-unit

    Annalee Armstrong FIERCE BIOTECH
    17 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search